Palisade Capital Management LLC NJ purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 161,014 shares of the company’s stock, valued at approximately $7,951,000.

Other hedge funds also recently modified their holdings of the company. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Acadia Healthcare during the first quarter worth about $210,000. Paloma Partners Management Co bought a new stake in shares of Acadia Healthcare during the first quarter worth about $217,000. M&T Bank Corp bought a new stake in shares of Acadia Healthcare during the first quarter worth about $230,000. World Asset Management Inc bought a new stake in shares of Acadia Healthcare during the second quarter worth about $242,000. Finally, Teacher Retirement System of Texas bought a new stake in shares of Acadia Healthcare during the first quarter worth about $258,000.

Shares of Acadia Healthcare Company, Inc. (ACHC) opened at 52.58 on Tuesday. The company has a market capitalization of $4.62 billion, a P/E ratio of 577.80 and a beta of 1.15. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $54.73. The stock’s 50 day moving average price is $48.90 and its 200 day moving average price is $44.01.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same quarter in the prior year, the company posted $0.73 EPS. The company’s quarterly revenue was down 5.4% on a year-over-year basis. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.dailypolitical.com/2017/08/08/palisade-capital-management-llc-nj-purchases-shares-of-161014-acadia-healthcare-company-inc-achc.html.

A number of analysts recently issued reports on the company. Mizuho raised their price target on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. BidaskClub upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, June 10th. Craig Hallum restated a “buy” rating and issued a $65.00 price target (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Leerink Swann downgraded Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Finally, UBS AG restated a “positive” rating and issued a $60.00 price target (up from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Five investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $59.21.

In other news, Director Reeve B. Waud sold 50,000 shares of the company’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $45.09, for a total value of $2,254,500.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director William Grieco sold 2,000 shares of the company’s stock in a transaction on Friday, June 16th. The shares were sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the transaction, the director now directly owns 47,013 shares in the company, valued at approximately $2,135,330.46. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,136,347 shares of company stock worth $105,383,249. Corporate insiders own 11.10% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.